Nu Skin Enterprises reported first-quarter revenue of $604.9 million and EPS of $0.76, outperforming guidance despite global uncertainties and COVID-related obstacles. Demand for new products like ageLOC® Meta and Beauty Focus™ Collagen+ drove growth in several markets, while Mainland China and EMEA were negatively impacted by COVID-related lockdowns and geopolitical conflict.
First quarter revenue reached $604.9 million, reflecting an 11% decrease year-over-year, with a 3% negative impact from foreign exchange rates.
Earnings per share (EPS) were reported at $0.76, a 16% decrease compared to the prior-year quarter.
The company saw a decrease in customer base to 1,321,451, a 13% reduction from the previous year.
Paid Affiliates decreased to 251,436, representing a 14% decline year-over-year.
Nu Skin provided revenue guidance for Q2 2022 of $590 to $620 million and EPS of $0.75 to $0.85. The company also adjusted its annual guidance to revenue of $2.51 to $2.62 billion and EPS of $3.60 to $3.90, reflecting ongoing global uncertainties.
Analyze how earnings announcements historically affect stock price performance